Market revenue in 2023 | USD 11.2 million |
Market revenue in 2030 | USD 20.9 million |
Growth rate | 9.3% (CAGR from 2023 to 2030) |
Largest segment | Biorepository services |
Fastest growing segment | Biorepository Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biorepository Services, Archiving Solution Services |
Key market players worldwide | Azenta Inc, Thermo Fisher Scientific Inc, Precision for Medicine, Medpace Holdings Inc, Labcorp Drug Development, ATCC, Q2 Solutions, LabConnect, Charles River Laboratories International Inc |
Biorepository services was the largest segment with a revenue share of 66.96% in 2023. Horizon Databook has segmented the Colombia clinical trial biorepository & archiving solutions market based on biorepository services, archiving solution services covering the revenue growth of each sub-segment from 2018 to 2030.
Colombia offers various benefits to life sciences companies such as pharmaceutical, biotechnology, and medtech companies to enhance quality ðical clinical research at a competitive cost.
There are various associated advantages for conducting clinical trials in Colombia such as 30.00% to 50.00% cost savings in clinical trials in comparison with the U.S. and Europe and access to around 50.00 million patients. Therefore, various CROs in the country offer clinical trial services to end users such as pharmaceutical and biotech companies.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account